Welcome to CDC Stacks | Costs and Benefits of an Organized Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in the United States - 34743 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Costs and Benefits of an Organized Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in the United States
Filetype[PDF - 390.50 KB]


Details:
  • Pubmed ID:
    24737634
  • Pubmed Central ID:
    PMC4593052
  • Description:
    BACKGROUND

    Despite clear recommendations and evidence linking colorectal cancer screening to lower incidence and mortality, >40% of adults are not up to date with screening. Existing domestic and international models of organized cancer screening programs have been effective in increasing screening rates. Implementing an organized, evidence-based, national screening program may be an effective approach to increasing screening rates.

    METHODS

    In the current study, the authors estimated the initial investment required and the cost per person screened of a nationwide fecal immunochemical test (FIT)-based colorectal cancer screening program among adults aged 50 years to 75 years.

    RESULTS

    The initial additional investment required was estimated at $277.9 to $318.2 million annually, with an estimated 8.7 to 9.4 million individuals screened at a cost of $32 to $39 per person screened. The program was estimated to prevent 2900 to 3100 deaths annually.

    CONCLUSIONS

    The results of the current study indicate that implementing a national screening program would make a substantial public health impact at a moderate cost per person screened. Results from this analysis may provide useful information for understanding the public health benefit of an organized screening delivery system and the potential resources required to implement a nationwide colorectal cancer screening program, and help guide decisions about program planning, design, and implementation.

  • Document Type:
  • Collection(s):
  • Funding:
    CC999999/Intramural CDC HHS/United States
No Related Documents.
You May Also Like: